Overcoming Challenges in Drug Discovery with Lilly TuneLab
- TuneLab provides access to Lilly-trained AI models to help accelerate breakthrough medicines to patients
- The platform employs federated learning, a privacy-preserving approach that enables biotech developers to tap into Lilly’s AI models without directly exposing their proprietary data
- Hear real-world examples from partners using TuneLab to accelerate their drug discovery work